$144 Million is the total value of Evolutionary Tree Capital Management, LLC's 38 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NYXOAH S A | $1,195,000 | -16.8% | 62,445 | 0.0% | 0.83% | +20.6% | ||
| V | VISA INC | $342,000 | +2.4% | 1,540 | 0.0% | 0.24% | +48.8% | |
| MELI | MERCADOLIBRE INC | $332,000 | -11.7% | 279 | 0.0% | 0.23% | +27.6% | |
| TTD | THE TRADE DESK INC | $329,000 | -24.4% | 4,750 | 0.0% | 0.23% | +9.6% | |
| ADBE | ADOBE SYSTEMS INCORPORATED | $257,000 | -19.7% | 565 | 0.0% | 0.18% | +16.2% | |
| CRM | SALESFORCE COM INC | $251,000 | -16.3% | 1,180 | 0.0% | 0.17% | +20.8% | |
| SPOT | SPOTIFY TECHNOLOGY S A | $217,000 | -35.4% | 1,437 | 0.0% | 0.15% | -6.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HUBSPOT INC | 12 | Q3 2023 | 8.0% |
| SERVICENOW INC | 12 | Q3 2023 | 8.2% |
| AMAZON COM INC | 12 | Q3 2023 | 8.8% |
| SAREPTA THERAPEUTICS INC | 12 | Q3 2023 | 7.9% |
| SEA LTD | 12 | Q3 2023 | 6.7% |
| ALPHABET INC | 12 | Q3 2023 | 6.0% |
| ARROWHEAD PHARMACEUTICALS IN | 12 | Q3 2023 | 3.7% |
| ARGENX SE | 12 | Q3 2023 | 4.1% |
| ASCENDIS PHARMA A/S | 12 | Q3 2023 | 3.1% |
| VISA INC | 12 | Q3 2023 | 5.0% |
View Evolutionary Tree Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View Evolutionary Tree Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.